Mami-Chouaib F - Search Results

1

CD103⁺CD8⁺ T_RM Cells Accumulate in Tumors of Anti-PD-1-Responder Lung Cancer Patients and Are Tumor-Reactive Lymphocytes Enriched with Tc17.

Corgnac S, Malenica I, Mezquita L, Auclin E, Voilin E, Kacher J, Halse H, Grynszpan L, Signolle N, Dayris T, Leclerc M, Droin N, de Montpréville V, Mercier O, Validire P, Scoazec JY, Massard C, Chouaib S, Planchard D, Adam J, Besse B, Mami-Chouaib F. Corgnac S, et al. Cell Rep Med. 2020 Oct 20;1(7):100127. doi: 10.1016/j.xcrm.2020.100127. eCollection 2020 Oct 20. Cell Rep Med. 2020. PMID: 33205076 Free PMC article.

2

Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors.

Chouaib S, Chehimi J, Bani L, Genetet N, Tursz T, Gay F, Trinchieri G, Mami-Chouaib F. Chouaib S, et al. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12659-63. doi: 10.1073/pnas.91.26.12659. Proc Natl Acad Sci U S A. 1994. PMID: 7809096 Free PMC article.

3

CD48 may serve as an accessory molecule for the activation of a subset of human gamma/delta T cells.

Flament C, Bellagha K, Rosenthal-Allieri A, Chouaib S, Mami-Chouaib F. Flament C, et al. Hum Immunol. 1996 Apr;46(2):82-92. doi: 10.1016/0198-8859(96)00010-9. Hum Immunol. 1996. PMID: 8727206

4

TCR alpha/beta and TCR gamma/delta CD4-/CD8- HLA-DR alloreactive CTL clones do not use Fas/Fas ligand pathway to lyse their specific target cells.

Mami-Chouaib F, Flament C, Asselin-Paturel C, Gaudin C, Chouaib S. Mami-Chouaib F, et al. Hum Immunol. 1996 Nov;51(1):13-22. doi: 10.1016/s0198-8859(96)00164-4. Hum Immunol. 1996. PMID: 8911993

5

Differential regulation of interleukin-12- and interleukin-15-induced natural killer cell activation by interleukin-4.

Salvucci O, Mami-Chouaib F, Moreau JL, Thèze J, Chehimi J, Chouaib S. Salvucci O, et al. Eur J Immunol. 1996 Nov;26(11):2736-41. doi: 10.1002/eji.1830261128. Eur J Immunol. 1996. PMID: 8921963

6

Functional interaction between TGF-beta and IL-12 in human primary allogeneic cytotoxicity and proliferative response.

Pardoux C, Asselin-Paturel C, Chehimi J, Gay F, Mami-Chouaib F, Chouaib S. Pardoux C, et al. J Immunol. 1997 Jan 1;158(1):136-43. J Immunol. 1997. PMID: 8977184

7

The host-tumor immune conflict: from immunosuppression to resistance and destruction.

Chouaib S, Asselin-Paturel C, Mami-Chouaib F, Caignard A, Blay JY. Chouaib S, et al. Immunol Today. 1997 Oct;18(10):493-7. doi: 10.1016/s0167-5699(97)01115-8. Immunol Today. 1997. PMID: 9357142 Review.

8

Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma.

Bagot M, Echchakir H, Mami-Chouaib F, Delfau-Larue MH, Charue D, Bernheim A, Chouaib S, Boumsell L, Bensussan A. Bagot M, et al. Blood. 1998 Jun 1;91(11):4331-41. Blood. 1998. PMID: 9596682 Free article.

9

Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients.

Asselin-Paturel C, Echchakir H, Carayol G, Gay F, Opolon P, Grunenwald D, Chouaib S, Mami-Chouaib F. Asselin-Paturel C, et al. Int J Cancer. 1998 Jul 3;77(1):7-12. doi: 10.1002/(sici)1097-0215(19980703)77:1<7::aid-ijc2>3.0.co;2-y. Int J Cancer. 1998. PMID: 9639386 Free article.

10

Analysis of T-cell-receptor beta-chain-gene usage in peripheral-blood and tumor-infiltrating lymphocytes from human non-small-cell lung carcinomas.

Echchakir H, Asselin-Paturel C, Dorothee G, Vergnon I, Grunenwald D, Chouaib S, Mami-Chouaib F. Echchakir H, et al. Int J Cancer. 1999 Apr 12;81(2):205-13. doi: 10.1002/(sici)1097-0215(19990412)81:2<205::aid-ijc7>3.0.co;2-m. Int J Cancer. 1999. PMID: 10188720 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

109 results

Search Page